Alzheon’s oral anti-amyloid drug has potential to be first oral Aβ-targeting therapy approved in US and EU: GlobalData Read more
Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil Read more
Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine Read more
How global healthcare partners and Indian pharma companies are contributing to affordable medicines Read more